Themis Medicare enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


907	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
4.5	4.5	6.6	9.9	12.5
−0.0	−0.0	−0.0	−0.0	−0.0
100	100	83.0	95.8	92.0
1,002	—	—	—	—
95.6	95.6	76.4	85.9	79.4
₹108.81	—	—	—	—

499	499	486	473	431
20.1%	20.1%	17.1%	20.2%	21.3%
0.10×	—	—	—	—

3.02×	—	—	—	—
−23.89×	—	—	—	—
−19.18×	—	—	—	—
332	342	406	382	354
−41.9	0.4	49.0	51.5	67.5
−52.3	−9.9	39.1	39.3	57.0
—	−3.3	34.7	14.5	16.1
−8.1	−8.1	19.3	−4.0	−12.7
—	−8.1	16.8	−6.6	−14.8
—	4.9	15.4	18.4	28.7

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

THEMISMED₹98.44

Themis Medicare Limited

· Pharma & Health

₹ CrorePeersLINCOLN BAJAJHCARE SIGACHI WANBURY AMRUTANJAN AHCLANUHPHRMcap ₹907 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	906.6
- Cash, Equiv & ST Investments	12.5	9.9	6.6	4.5	4.5
+ Minority Interest	-0.0	-0.0	-0.0	-0.0	-0.0
+ Total Debt	92.0	95.8	83.0	100.1	100.1
Enterprise Value	—	—	—	—	1,002.2
Net Debt (memo)	79.4	85.9	76.4	95.6	95.6
EV per Share	—	—	—	—	108.81

Total Capital	431.4	473.5	485.6	498.7	498.7
Total Debt/Total Capital	21.32	20.23	17.09	20.07	20.07
Total Debt/EV	—	—	—	—	0.10

EV/Sales	—	—	—	—	3.02
EV/EBITDA	—	—	—	—	-23.89
EV/EBIT	—	—	—	—	-19.18
Reference Items — Trailing FY Values
Sales	354.3	381.8	405.5	342.2	331.6
EBITDA	67.5	51.5	49.0	0.4	-41.9
EBIT	57.0	39.3	39.1	-9.9	-52.3
Operating Cash Flow	16.1	14.5	34.7	-3.3	—
Free Cash Flow	-12.7	-4.0	19.3	-8.1	-8.1
FCFF (free cash flow to the firm)	-14.8	-6.6	16.8	-8.1	—
Capital Expenditure	28.7	18.4	15.4	4.9	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.